These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13836792)

  • 41. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MALIGNANT INTRA-ABDOMINAL TUMOURS.
    JOLLEYS A
    Br J Clin Pract; 1965 Jun; 19():323-30. PubMed ID: 14328280
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of low doses of actinomycin D on neuroblastoma cell lines.
    Cortes CL; Veiga SR; Almacellas E; Hernández-Losa J; Ferreres JC; Kozma SC; Ambrosio S; Thomas G; Tauler A
    Mol Cancer; 2016 Jan; 15():1. PubMed ID: 26728659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells.
    Papahadjopoulos D; Poste G; Vail WJ; Biedler JL
    Cancer Res; 1976 Sep; 36(9 pt.1):2988-94. PubMed ID: 975068
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Actinomycin D: toxic effects with special reference to hepatic injury].
    Mihevc-Srakar N; Petrić-Grabnar G
    Bilt Hematol Transfuz; 1979; 7(1):85-90. PubMed ID: 552251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RECOVERY FROM BILATERAL WILMS' TUMORS.
    JOHNSTON JH; SHAH MB
    Clin Pediatr (Phila); 1965 Jul; 4():394-6. PubMed ID: 14314504
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sanamycin--observations and critical considerations].
    DOKTORCZYK H
    Pol Tyg Lek; 1960 Dec; 15():1971-3. PubMed ID: 13723491
    [No Abstract]   [Full Text] [Related]  

  • 48. Further investigations about actinomycin D action on mouse erythropoietin responsive cell.
    Moreau-Gachelin F; Wendling F; Charon M; Tambourin PE
    Biomedicine; 1979 Jun; 30(2):112-7. PubMed ID: 476265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A report of an actinomycin D study group in Japan.
    Takatsu T
    Paediatr Univ Tokyo; 1970 Jan; 17():7-9. PubMed ID: 4315852
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of actinomycin D on cell proliferation induced by phytohemagglutinin in human lymphocytes].
    Pospelova TV
    Tsitologiia; 1975 Jun; 17(6):660-6. PubMed ID: 1154496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatopathy-Thrombocytopenia Syndrome During Actinomycin D Treatment May Be Related to MDR1 (ABCB1) Gene Polymorphisms.
    Baskin Y; Amirfallah A; Calibasi G; Olgun N
    Am J Ther; 2016; 23(2):e594-6. PubMed ID: 24413370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
    Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of Wilms tumor using carboplatin compared to therapy without carboplatin.
    Acipayam C; Sezgin G; Bayram İ; Yılmaz S; Özkan A; Tuncel DA; Tanyeli A; Küpeli S
    Pediatr Blood Cancer; 2014 Sep; 61(9):1578-83. PubMed ID: 24729447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood cancer.
    HUNTER AL
    Wis Med J; 1960 Mar; 59():209-10. PubMed ID: 14405442
    [No Abstract]   [Full Text] [Related]  

  • 55. [Aspects of cancer in childhood].
    GUBERN SALISACHS L
    Rev Mex Cir Ginecol Cancer; 1961 Sep; 29():267-71. PubMed ID: 13902575
    [No Abstract]   [Full Text] [Related]  

  • 56. The paediatric and the geriatric aspects of cancer.
    PAYMASTER JC
    J Indian Med Assoc; 1962 Aug; 39():163-6. PubMed ID: 14484675
    [No Abstract]   [Full Text] [Related]  

  • 57. Cancer in childhood.
    AREY JB
    Med Clin North Am; 1952 Nov; 36(6):1797-1806. PubMed ID: 12992139
    [No Abstract]   [Full Text] [Related]  

  • 58. Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
    Rusert JM; Juarez EF; Brabetz S; Jensen J; Garancher A; Chau LQ; Tacheva-Grigorova SK; Wahab S; Udaka YT; Finlay D; Seker-Cin H; Reardon B; Gröbner S; Serrano J; Ecker J; Qi L; Kogiso M; Du Y; Baxter PA; Henderson JJ; Berens ME; Vuori K; Milde T; Cho YJ; Li XN; Olson JM; Reyes I; Snuderl M; Wong TC; Dimmock DP; Nahas SA; Malicki D; Crawford JR; Levy ML; Van Allen EM; Pfister SM; Tamayo P; Kool M; Mesirov JP; Wechsler-Reya RJ
    Cancer Res; 2020 Dec; 80(23):5393-5407. PubMed ID: 33046443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies.
    Gilles A; Frechin L; Natchiar K; Biondani G; Loeffelholz OV; Holvec S; Malaval JL; Winum JY; Klaholz BP; Peyron JF
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case report of cold-weather-induced radiation recall dermatitis after chemoradiotherapy with cisplatin.
    Kindts I; Stellamans K; Bonny M; Planckaert N; Goethals L
    Strahlenther Onkol; 2014 Aug; 190(8):762-6. PubMed ID: 24699987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.